3,560 material Form 8-K filings that 2,489 companies we cover made with the SEC in October 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 2,508 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
A Delaware Court of Chancery granted FBB Holdings I's motions and enjoined Destination XL from terminating its merger agreement with FBB while the court makes further expedited determinations. The order is temporary and not a ruling on the merits, and DXL says it believes FBB's claims are without merit and will defend against them.
The Court of Chancery held a hearing on October 29, 2026 and granted both motions after it.
The merger agreement, dated December 11, 2025, allows either party to terminate if the merger is not completed by October 30, 2026.
FBB filed its complaint on October 26, 2026; DXL filed an answer and counterclaims on October 28, 2026.
DXL's preliminary proxy statement was filed July 17, 2026 and amended most recently on October 19, 2026.
Ingersoll Rand's board approved an amended employment agreement with Chairman and CEO Vicente Reynal that extends his initial term to February 29, 2032, raises his base salary from $1.1 million to $1.2 million, and adds a performance-based equity award. The filing also reports that Senior Vice President Michael Weatherred retired effective immediately, and that Scott Watson and Shaun Carlson were promoted to group president roles. For shareholders, the new CEO award vests only if Adjusted EPS grows at a compound annual rate of at least 8% to 10% over five years.
Reynal's base salary rises from $1.1 million to $1.2 million; target bonus stays at 150% of base salary
Expected grant on November 23, 2026 of 226,098 performance stock units, valued at about $17.1 million, vesting on Adjusted EPS CAGR of 8% (50%) to 10% (100%) over 2027-2031
Michael Weatherred retired effective immediately after notice on October 27, 2026, and will serve in an advisory role through May 2028
Scott Watson and Shaun Carlson named senior vice presidents and group presidents, both internal promotions reporting to Reynal
Rapport Therapeutics closed an underwritten offering of common stock and pre-funded warrants and a $172.5 million offering of 2.25% convertible senior notes due 2032 on October 30, 2026. The company estimates net proceeds of about $215.7 million from the stock offering and $166.8 million from the notes, which it plans to use mainly to fund clinical trials of RAP-219, and it expects these funds plus existing cash to support operations through the end of 2029. Shareholders face dilution from the new shares and the potential conversion of the notes, and the company now carries a new debt obligation.
Stock offering: 8,333,334 firm shares at $21.00 each, plus 1,428,571 option shares exercised in full on October 28, 2026, and pre-funded warrants for up to 1,190,476 shares
Estimated net proceeds of $215.7 million from the stock offering and $166.8 million from the notes
$172.5 million of 2.25% convertible senior notes due December 1, 2032, with an initial conversion price of about $26.7750 per share
Notes offering closed October 30, 2026; the company says proceeds will fund operations through the end of 2029
TriCo Bancshares stockholders voted on October 29, 2026 to approve the merger agreement with First Hawaiian, Inc., under which TriCo will merge into First Hawaiian. First Hawaiian shareholders also approved the share issuance, and the companies expect the transaction to close later in 2026, subject to remaining closing conditions. The vote clears a key stockholder approval step but does not complete the deal.
Merger Proposal approved: 24,113,014 for, 223,343 against, 29,594 abstain
Non-binding Compensation Proposal approved: 22,950,706 for, 1,287,428 against, 127,816 abstain
Record date September 11, 2026; 31,966,630 shares outstanding; 24,365,951 shares present, constituting a quorum
Companies expect the transaction to close later in 2026, subject to remaining customary closing conditions
HF Sinclair agreed to repurchase 2,350,000 common shares from its largest holder, REH Advisors Inc., at $109.37 per share, or about $257 million in total, with completion expected on or around November 3, 2026. The filing says the REH Parties are expected to fall below the 5%-to-15% ownership range that gives them a right to designate a Board member, which could lead to that designee offering to resign by early 2027.
Shares: 2,350,000 common shares at $109.37 each, about $257 million total, funded with cash on hand
Expected completion: on or around November 3, 2026; shares will be held as treasury stock
Program status: $766 million repurchased to date under the $1.5 billion program authorized August 26, 2026, leaving about $734 million
Board: REH Designee must offer to resign within 30 days after January 13, 2027 if REH Parties remain below the 15% designation threshold
Utz Brands disclosed that CEO Howard Friedman will leave the company after the merger with Intersnack-linked buyers closes, with his employment expected to end November 30, 2026, and that he will leave the board at closing. The company also said board member B. John Lindeman received an offer to become CEO of Utz's post-closing operating company, subject to closing and a written employment agreement.
Friedman's employment is expected to end November 30, 2026, contingent on the merger closing; he leaves the board at closing
Friedman said his decision was not due to any disagreement with the company, Parent, or continuing stockholders
Lindeman received a letter agreement on October 29, 2026 offering the CEO role at Company LLC, with a contemplated start of November 30, 2026
Special meeting of stockholders is scheduled for November 13, 2026; two stockholder complaints were filed October 22, 2026, which the company says are without merit
Xcel Energy entered into a new equity distribution agreement on October 30, 2026, allowing it to sell up to $6.0 billion of common stock through sales agents, including forward sale arrangements. The filing also terminated its prior at-the-market program dated May 1, 2026, while forward sale agreements from earlier programs remain outstanding, so shareholders should note the potential for additional shares to be issued.
Up to $6.0 billion aggregate gross sales price of common stock (par value $2.50 per share) under the new Equity Distribution Agreement dated October 30, 2026
Prior at-the-market program dated May 1, 2026 was terminated; about $448.6 million of shares remained unsold at termination
About $3.8 billion of shares remain subject to outstanding forward sale agreements from the prior program, and about $2.2 billion from an August 1, 2025 agreement
Xcel Energy will not initially receive proceeds from borrowed shares sold under forward agreements; proceeds are expected on future physical settlement
Equity LifeStyle Properties said Patrick Waite will succeed Marguerite Nader as President and Chief executive officer effective January 1, 2027, and Waite will also join the Board. Nader will remain on the Board as Executive Vice Chair, and David Eldersveld will become Chief Operating Officer, as part of a multi-year succession plan. The filing reports no financial results or guidance changes.
Nader ceases to be Vice Chairman and CEO on December 31, 2026 and becomes Executive Vice Chair of the Board on January 1, 2027.
Waite, 60, becomes President and CEO on January 1, 2027 and is elected to the Board, which increases from nine to ten directors.
Waite's approved 2027 base salary is $614,935, with bonus potential of 290% of base salary; Eldersveld's is $476,558, with bonus potential of 220%.
The Board declared a fourth quarter 2026 dividend of $0.5425 per share, payable January 8, 2027 to holders of record on December 24, 2026.
Norwegian Cruise Line Holdings' subsidiary NCL Corporation signed two credit facility agreements on October 27, 2026, providing up to approximately $2.5 billion for each of two new cruise vessels, for total borrowing capacity of about $5 billion. The loans are backed by Italian state export credit agency SACE, which insures 100% of the loans subject to conditions, and the filing does not report any effect on the company's earnings or results.
Two facilities signed October 27, 2026, each up to approximately $2.5 billion, for Vessel 1 (delivery 2034) and Vessel 2 (delivery 2036)
Floating rate of six-month Term SOFR plus a 0.90% margin, with customary agency, structuring and commitment fees
Loans repaid in twenty-four equal semi-annual installments beginning six months after each ship's delivery; guaranteed by NCL Corporation
Facilities fund 80% of delivery payments under the shipbuilding contracts and are insured by SACE, subject to conditions
Peoples Bancorp Inc. completed its acquisition of Citizens National Corporation effective at the close of business on October 30, 2026, following a merger agreement first announced on April 21, 2026. Citizens had approximately $646 million in total assets at September 30, 2026, and its shareholders received 2.10 shares of Peoples common stock plus $8.00 in cash for each Citizens share.
Citizens had about $646 million in total assets, $344 million in total loans and $551 million in total deposits at September 30, 2026.
Each Citizens common share was exchanged for 2.10 Peoples common shares plus $8.00 in cash.
Citizens' 12 branches will operate initially as a division of Peoples Bank and convert to Peoples Bank branches after the close of business on April 19, 2027.
Verra Mobility said CFO Craig Conti will resign effective November 4, 2026. The Board appointed Matthew Kvarda, a Managing Director at Alvarez & Marsal, as interim CFO effective November 5, 2026, while a search firm assists in finding a permanent CFO. Kvarda's services are provided through an engagement with Alvarez & Marsal, which the company pays directly, and he will not receive compensation from Verra Mobility.
Craig Conti resigns as Executive Vice President and Chief Financial Officer effective November 4, 2026.
Matthew Kvarda, 56, is appointed interim CFO and principal financial officer effective November 5, 2026, until a permanent CFO is appointed.
Verra Mobility will pay Alvarez & Marsal $150,000 per month plus expenses, rising to $165,000 from May 1, 2027; fees through October 31, 2027 may not exceed $1,890,000 without consent.
Spencer Stuart is assisting the Board in the search for a permanent Chief Financial Officer.
Tempest Therapeutics said Chief Financial Officer Constance Ames resigned effective immediately on October 26, 2026, citing personal considerations unrelated to the company. The board appointed Stephanie Horn-Warnock as CFO, principal financial and accounting officer, treasurer and corporate secretary, also effective immediately, and she will work for the company as a consultant under an engagement letter dated October 28, 2026.
Constance Ames resigned as CFO and from all other company positions, effective immediately, for personal considerations unrelated to the company.
Stephanie Horn-Warnock, 37, was appointed CFO effective immediately on October 26, 2026.
Horn-Warnock previously was Vice President of Finance at ROM Technologies Inc. from January 2024 to September 2026.
Under her consulting engagement letter dated October 28, 2026, the company will pay $450 per hour plus expenses and an indirect cost allocation of 5.0% of total professional fees.
System1, Inc. said its President and Chief Operating Officer, Charles Ursini, resigned effective at the close of business on October 30, 2026. He will stay on the Board of Directors and serve as a strategic advisor to management, and the filing gives no replacement or financial details.
Charles Ursini resigned as President and Chief Operating Officer, effective close of business October 30, 2026
Ursini notified the company of the resignation on October 26, 2026
He had served as President and COO since April 2024
He will continue as a director and strategic advisor to management
On October 29, 2026, Texas Community Bancshares (TCBS) entered into a merger agreement to acquire The Banc of San Jacinto County Bancshares, the holding company for The Bank of San Jacinto County in Coldspring, Texas, for aggregate cash consideration of $9.5 million, funded with cash on hand and not subject to a financing condition. The target bank had total assets of $41.951 million as of June 30, 2026, and the merger is expected to close in the first quarter of 2027, subject to shareholder and regulatory approvals.
Merger Agreement signed October 29, 2026; SJCB merges into TCBS, and its bank merges into Broadstreet Bank, SSB
Aggregate cash consideration of $9.5 million, with TCBS expecting to fund it from cash on hand
SJCB Bank reported total loans of $12.515 million and total deposits of $35.305 million as of June 30, 2026
Closing expected in Q1 2027; requires approval by holders of two-thirds of SJCB shares and regulatory approvals; SJCB owes a $550,000 termination fee in specified cases
Green Plains entered into a Tax Credit Purchase Agreement on October 29, 2026, to transfer Section 45Z clean fuel production tax credits from its 2026 ethanol production to two unaffiliated buyers. The deal covers a minimum of $250 million and up to $325 million in credits, and the company expects $140 million of cash in the fourth quarter for credits generated through June 30, 2026.
Minimum of $250 million and maximum of $325 million in 2026 Section 45Z credits, subject to generation and conditions
Company expects $140 million cash in Q4 2026 for credits generated through June 30, 2026
Credits from Q3 and Q4 2026 expected to be monetized in the first half of 2027
If a tax law change limits transferred credits, Green Plains must return the related purchase price with interest
Hilton Grand Vacations agreed on October 30, 2026 to repurchase $200 million of its common stock through an accelerated share repurchase with Deutsche Bank AG, London Branch. The company paid $200 million up front and received an initial delivery of approximately 4.48 million shares, with the final share count to be set at settlement based on volume-weighted average price, less a discount.
Company pays $200 million to the Dealer on October 30, 2026 and receives an initial delivery of approximately 4.48 million shares.
Final share count depends on the volume-weighted average price over the calculation period, less a discount; the Dealer may deliver additional shares at settlement.
Final settlement is expected no later than December 31, 2026, and the Dealer may accelerate the termination date on or after December 1, 2026.
Pluri Inc. entered into a partnership agreement with ZEO ScientifiX on October 26, 2026, under which ZEO would receive an exclusive US license to manufacture and commercialize Pluri's regenerative medicine products, with Pluri receiving equity in ZEO at closing. On October 27, 2026, Pluri agreed to sell 909,092 common shares and warrants to two investors for $1.0 million in total, with closing expected on or before October 30, 2026. The stock sale adds shares outstanding, and the ZEO transaction depends on closing conditions, including agreement on an operating plan.
October 26, 2026: ZEO partnership grants ZEO an exclusive US license to manufacture and commercialize Pluri's regenerative medicine products, excluding certain aesthetics, skin care, cosmetic, or veterinary uses, which ZEO may only commerci
At closing, Pluri is to receive 41% of ZEO's issued and outstanding shares plus 50 Series D Preferred shares carrying 51% of ZEO's votes
October 27, 2026: two Securities Purchase Agreements for 909,092 common shares at $1.10 per share, with warrants for an equal number of shares at $1.30 per share; closing expected on or before October 30, 2026
NextCure said its Chief Medical Officer, Dr. Udayan Guha, will be terminated effective October 31, 2026, in connection with the pending merger with Avere Therapeutics, Inc. He signed a severance agreement and release, and additional change-in-control severance is payable only if the merger closes.
Dr. Udayan Guha, Chief Medical Officer and a named executive officer, is terminated effective October 31, 2026.
The departure is tied to the pending merger of NextCure and Avere Therapeutics, Inc.
Severance follows his existing employment agreement; enhanced change-in-control severance applies only if the merger closes.
The filing does not state the dollar amount of severance.
LCI Industries' board unanimously determined that Monomoy Capital Partners' unsolicited, non-binding $101-per-share cash proposal is not a superior proposal and is not reasonably likely to lead to one. The board reiterated its support for the pending merger with Patrick Industries, which it expects to complete in the first half of 2027. Shareholders are asked to vote in favor of the Patrick merger at a special meeting scheduled for November 18, 2026.
Monomoy Capital Partners proposed $101 per share in cash for all LCI shares, announced October 28, 2026
LCI board says its standalone discounted cash flow value is in excess of $150 per share
Merger with Patrick expected to yield approximately $150 million in net run-rate cost synergies within three years of closing
Special shareholder meeting on the Patrick merger scheduled for November 18, 2026
After Churchill Capital Corp XI's redemption deadline expired, Agility Robotics said its gross capital raise tied to the proposed business combination is expected to be about $465 million before transaction expenses. The business combination is expected to close on November 4, 2026, subject to Churchill XI shareholder approval, with the combined company expected to trade on Nasdaq under ticker AGLT from November 5, 2026. The filing gives no revenue or profit figures, and the final cash available to Agility depends on how many Churchill XI shareholders keep their redemption elections.
Gross capital raise expected to be about $465 million before transaction expenses, following the expiration of Churchill XI's redemption deadline.
Sources: about $164 million from the Churchill XI trust account, about $201 million from a common stock PIPE at $10 per share led by Foxconn, and $100 million of equity funding already received.
Churchill XI shareholder vote is scheduled at an extraordinary general meeting on November 2, 2026; closing is expected November 4 and Nasdaq trading November 5.
Churchill XI shareholders who asked to redeem their shares may withdraw that request at any time before the scheduled vote.
Genworth Financial said President and CEO Thomas J. McInerney will retire and leave its board effective December 31, 2026. Jerome T. Upton, the company's CFO, will become President and CEO and join the board effective January 1, 2027, and Angela R. Simmons will become Executive Vice President and CFO on the same date.
Thomas J. McInerney retires as President and CEO and resigns from the board effective December 31, 2026.
Jerome T. Upton, currently CFO, is to become President and CEO and a board member effective January 1, 2027.
Angela R. Simmons, currently CFO of the Closed Block, is to become Executive Vice President and CFO effective January 1, 2027.
The filing says McInerney's retirement is not the result of any disagreement with the company, and compensation terms for Upton and Simmons will be disclosed later by amendment.
Valero Energy agreed to acquire LYB Houston Hub Holdings, which owns an approximately 700-acre facility next to Valero's Houston refinery, from a LyondellBasell subsidiary for $320.5 million, subject to closing adjustments. Valero expects to initially restart 165,000 barrels per day of light sweet crude processing capacity by year-end 2027, and the deal is expected to close by the end of 2026.
Purchase price is $320.5 million, subject to closing adjustments; agreement signed October 29, 2026
Closing depends on customary conditions, including expiration or termination of the Hart-Scott-Rodino antitrust waiting period
Valero expects to initially restart 165,000 barrels per day of light sweet crude capacity by year-end 2027
Company says the acquisition may later support investment in high-complexity, heavy sour crude processing
Repligen plans to issue $1.0 billion of 0.25% convertible senior notes due 2031, with about $541.4 million issued in exchange for $456.8 million of its 1.00% notes due 2028 and about $458.6 million sold for cash. The company says it will use about $120.0 million of the cash proceeds to repurchase common stock at $188.64 per share, and closing is expected on or about November 6, 2026. For shareholders, the deal refinances part of the 2028 notes and could lead to up to 5,301,100 new shares on conversion, while the related share repurchases could affect the stock price.
Exchange: about $456.8 million of 2028 notes swapped for about $541.4 million of new notes; the company receives no cash from this part.
Cash sale: about $458.6 million of new notes sold for cash, with about $120.0 million used to repurchase shares at $188.64.
Initial conversion price is about $226.37, a 20.0% premium to the October 29, 2026 last sale price; up to 5,301,100 shares could be issued on conversion.
Closing is expected on or about November 6, 2026; about $143.2 million of 2028 notes will remain outstanding.
Estrella Immunopharma appointed Cynthia Pussinen as Chief Executive Officer and Chairperson of the Board effective October 25, 2026, replacing Cheng Liu, Ph.D., who became Chief Scientific Officer while remaining President and a director. The filing also sets Pussinen's pay package, including a 1,000,000-share option grant and base salary increases tied to future financing, and says the Board adopted a plan to propose a change to its director class structure for stockholder vote in 2027.
Cynthia Pussinen, age 57, appointed CEO, Class I director and Board Chairperson effective October 25, 2026
Pussinen's base salary is $250,000, rising to $400,000, $450,000 and $525,000 as cumulative qualifying funding after October 25, 2026 exceeds $35.0 million, $55.0 million and $75.0 million
Option to purchase 1,000,000 shares granted on the second business day after the filing, with 25% vesting on October 25, 2027
Proposed amendment to Article V, Section A to be submitted to stockholders at the 2027 annual meeting
Dine Brands' board adopted a limited duration stockholder rights agreement on October 28, 2026, in response to media reports of significant open market accumulation in its stock and derivatives. The plan issues one right per common share to holders of record on November 9, 2026, and the rights generally become exercisable only if a person or group acquires 10% or more (20% for passive investors) without board approval.
Rights dividend: one right per common share, record date November 9, 2026
Exercise price of $210.00 per right, subject to adjustment; rights expire October 27, 2027 unless redeemed or exchanged earlier
Triggers at 10% beneficial ownership for non-passive investors and 20% for passive investors; the company may redeem rights at $0.001 each
Filing states stockholders are not required to take any action at this time
Kimberly-Clark completed a $4.9 billion private offering of five tranches of senior unsecured notes due 2028 through 2036. The company says it will use the proceeds, with cash on hand and commercial paper borrowings, to pay the cash consideration for its proposed acquisition of Kenvue and related fees. If the Kenvue acquisition is not completed by the outside date, or the company says it will not pursue it, the notes must be redeemed at 101% of principal plus accrued interest.
Five tranches total $4.9 billion: $750 million due 2028 at 5.100%, $1.0 billion due 2029 at 5.300%, $1.25 billion due 2031 at 5.450%, $750 million due 2034 at 5.650%, and $1.15 billion due 2036 at 5.800%.
The remaining $3.9 billion of JPMorgan Chase bridge loan commitments, of the original $7.7 billion, was terminated on October 29, 2026, after the note sale closed.
Special mandatory redemption at 101% applies if the Kenvue acquisition is not completed within five business days after the later of May 31, 2027 or any later agreed outside date.
Meta Platforms closed an offering of 250,000,000 Series A depositary shares on October 29, 2026, each representing a 1/20th interest in a 6.50% Series A Mandatory Convertible Preferred Stock. The company also entered forward sale agreements covering 40,000,000 Class A common shares, under which it will receive no initial proceeds and will issue shares later at an adjustable forward price. The preferred terms bar common dividends and buybacks while preferred shares remain outstanding, subject to exceptions, which may limit capital returns to common shareholders.
250,000,000 Series A depositary shares offered; underwriters have an option for up to 37,500,000 more, exercisable within 30 days
Offering closed October 29, 2026; certificates of designations filed with Delaware October 28, 2026
Forward sale agreements cover 40,000,000 Class A common shares, with initial forward sale price of $622.91875 per share and settlement by November 19, 2027
While preferred shares are outstanding, no common dividends or distributions may be paid, subject to certain exceptions
Southern Missouri Bancorp's Chief Financial Officer, Stefan Chkautovich, resigned effective November 7, 2026, to pursue another professional opportunity. The company's President and Chief Administrative Officer, Matthew T. Funke, a former CFO from 2006 to 2022, will become principal financial officer, and the filing says no new compensation arrangements were made for that role.
Chkautovich, CFO since August 31, 2023, informed the company and Southern Bank of his resignation on October 26, 2026, effective November 7, 2026.
Matthew T. Funke, President and Chief Administrative Officer, was appointed principal financial officer upon the resignation taking effect.
Funke and the company did not enter into, and do not anticipate, any compensatory arrangements for the appointment.
At the October 26, 2026 annual meeting, shareholders re-elected or elected directors Rebecca M. Brooks, David L. McClain and Mary Jane Judy to terms ending in 2029, approved the say-on-pay vote, and ratified FORVIS MAZARS, LLP as auditor fo
ADT Inc. agreed on October 29, 2026 to merge with Abode Parent, LLC, and its subsidiary Abode Merger Sub, Inc., in a deal where each common and Class B share would be converted into $10.00 in cash. The merger requires stockholder approval and other customary conditions, and the company's board unanimously approved the agreement. Shareholders would receive cash for their shares if the deal closes, and the agreement includes a 'go-shop' period that allows ADT to seek rival offers until November 29, 2026.
Merger consideration is $10.00 per share in cash for Common Stock and Class B Common Stock, without interest.
Go-shop period runs until November 29, 2026, with an extension to December 8, 2026 for certain excluded parties.
ADT would pay a termination fee of $227 million, or $114 million if it switches to a superior proposal during the go-shop period or extension; Parent would pay ADT a $473 million termination fee in certain cases.
Either party may terminate if the merger is not completed by July 29, 2027; Apollo Funds provided equity, preferred equity and debt financing commitments.
Summit Hotel Properties appointed Michael Nieves as Executive Vice President and Chief Financial Officer and promoted Adam Wudel to Executive Vice President and Chief Operating Officer, both effective November 1, 2026. Nieves most recently served as Senior Vice President of Finance and Treasurer at PENN Entertainment, and Wudel has been the Company's Executive Vice President of Corporate Development since 2024, so both changes put the Company's finance and operations leadership in new roles at the same time.
Michael Nieves becomes CFO effective November 1, 2026, with a $450,000 base salary and a time-based restricted stock award valued at $750,000.
Adam Wudel becomes COO effective November 1, 2026, with a $450,000 base salary; he has been with the Company since its 2011 IPO.
Both employment agreements run from November 1, 2026 to November 1, 2027, renewing automatically for one-year terms unless either party gives at least 30 days' notice.
Donaldson Company, Inc. entered into a Note Purchase Agreement on October 27, 2026, allowing it to issue up to $1.5 billion of senior unsecured notes in private placements. An initial $250 million series of notes, with maturities from 2032 to 2037 and fixed rates from 5.93% to 6.23%, is expected to be issued on January 12, 2027, subject to closing conditions.
Agreement permits up to $1,500,000,000 aggregate principal of senior unsecured notes in one or more series
Initial Series 2026-A notes total $250 million: $125 million at 5.93% due 2032, $75 million at 6.10% due 2034, $50 million at 6.23% due 2037
Notes expected to be issued January 12, 2027, subject to closing conditions
Agreement includes debt to EBITDA and priority debt covenants, and requires an offer to prepay notes upon a change in control
Hormel Foods disclosed that John F. Ghingo's employment agreement, which was tied to his role as President and was set to expire December 31, 2026, terminated October 26, 2026 under an October 23, 2026 letter agreement, as he took on the additional role of Chief Executive Officer. The filing says Ghingo now has no specified term as President and CEO, which is a governance detail rather than a change in operations or financial results.
John F. Ghingo began serving as President and Chief Executive Officer effective October 26, 2026, and continues on the Board of Directors.
His prior Employment Agreement, scheduled to expire December 31, 2026, terminated as of October 26, 2026.
The Letter Agreement was entered into October 23, 2026; the filing states he has no specified term as President and CEO.
The full Letter Agreement is expected to be filed as an exhibit to the Form 10-K for the fiscal year ended October 25, 2026.
Mineralys Therapeutics and Tanabe Pharma terminated the License Agreement for lorundrostat on October 27, 2026, and Tanabe assigned the related patents and know-how to Mineralys. Mineralys remains obligated to pay Tanabe the milestone payments under a separate Payment Obligation Agreement, and Tanabe keeps a first-negotiation right for Japan. The filing says the company incurred no material early termination penalties, and the $100.0 million change-of-control payment is no longer tied to the license terms that existed before.
License Agreement terminated and Transferred Intellectual Property assigned to Mineralys on October 27, 2026
Mineralys still owes Tanabe commercial milestone payments of up to $255.0 million plus up to $10.0 million for a potential second indication
Tanabe's right of first negotiation survives for Japan while milestones remain unpaid
No material early termination penalties incurred; full agreements to be filed with the 2026 Form 10-K
On October 28, 2026, DoorDash agreed to acquire Instacart (Maplebear Inc.) in a deal valued at about $17 billion, or $65.00 per Instacart share. Instacart stockholders can elect cash, DoorDash stock, or a mix, with stock capped at 25% of the aggregate consideration, so the deal is at least 75% cash. The transaction is expected to close in late 2027 or the first half of 2028, subject to Instacart stockholder approval and regulatory clearances.
Instacart holders can elect $65.00 in cash, 0.3372 DoorDash Class A shares, or $48.75 in cash plus 0.0843 shares; the $65.00 value is a 26% premium to Instacart's October 22, 2026 close
Instacart must pay a $650 million termination fee in specified circumstances; DoorDash must pay $1.25 billion if antitrust issues block the deal after the Outside Date
DoorDash plans to fund the cash portion with cash on hand and debt, backed by a 364-day bridge loan commitment from JPMorgan Chase Bank, N.A.; the deal has no financing condition
Stockholders holding about 19% of Instacart's outstanding shares have agreed to vote in favor; the deal requires HSR, Canadian and Israeli approvals
U.S. Bancorp said Vice Chair and Chief Risk Officer Jodi L. Richard resigned effective immediately to take a position at another publicly traded company, and that the resignation was not due to any disagreement with the company. Executive Vice President and Chief Credit Officer Troy W. Remington will serve as interim Chief Risk Officer while the company selects a successor.
Jodi L. Richard notified the company of her resignation on October 23, 2026, effective immediately
Resignation was not due to any disagreement with the company on operations, policies or practices
Troy W. Remington, Executive Vice President and Chief Credit Officer, is interim Chief Risk Officer
The company has not yet named a permanent successor
The Clorox Company's board appointed Fabian Garcia, currently president of Unilever Personal Care, as chief executive officer effective January 5, 2027. Linda Rendle steps down as CEO and chair on that date and will serve as a senior advisor through April 2, 2027, while Matthew Shattock becomes independent chair. The filing lists Garcia's offer terms, including a $100,000 base salary and an $11,000,000 sign-on RSU award, and the company's first-quarter fiscal 2027 earnings are scheduled for November 2.
Fabian Garcia appointed CEO effective January 5, 2027; he will also join the board
Linda Rendle steps down as CEO and director on January 5, 2027, and advises through April 2, 2027
Matthew Shattock to become independent chair, with a $225,000 chair retainer
Garcia's offer letter includes a $100,000 base salary, $2,000,000 target annual bonus and $11,000,000 one-time sign-on RSU award
First Mid Bancshares agreed on October 28, 2026 to acquire Evergreen Bancshares, parent of American Bank of Freedom, for 0.4081 First Mid shares plus $5.20 in cash per Evergreen share, about $70.7 million in aggregate based on First Mid's October 27 closing price of $51.01. The deal is expected to close in the first quarter of 2027, subject to regulatory and Evergreen shareholder approvals, and First Mid estimates about 5% EPS accretion in 2028 and tangible book value dilution of about 0.5%. Shareholders should note that the company expects to cross $10 billion in assets as a result of the transaction and that the filing says the figures are illustrative and may change.
Consideration: 0.4081 First Mid shares plus $5.20 cash per Evergreen share; about 1,109,690 First Mid shares and $14.1 million in cash in total, roughly 80% stock and 20% cash
Target: American Bank of Freedom had about $932 million in assets, $712 million in loans and $727 million in deposits as of September 30, 2026, with 10 banking centers
Timing: closing expected in the first quarter of 2027; bank merger and systems conversion expected in the second quarter of 2027
Pro forma estimates: about 5.0% EPS accretion in 2028, tangible book value dilution of about 0.5%, earnback of about 0.5 years, and about $13.8 million in pre-tax transaction costs
Norwegian Cruise Line announced that Meghan Montana, currently Chief Strategy Officer, will become Executive Vice President and Chief Financial Officer on January 1, 2027, replacing Mark Kempa, who moves to a special advisor role through June 30, 2027. The filing sets out Montana's $875,000 base salary and Kempa's transition terms, which matter to shareholders because they mark a change in the leader of the company's finances.
Meghan Montana becomes CFO effective January 1, 2027; her base salary is $875,000 per year.
Mark A. Kempa remains CFO through December 31, 2026, then serves as Special Advisor to the CEO until his separation date of June 30, 2027.
Montana's sign-on bonus totals $1,550,000, with two $400,000 installments payable after March 1, 2027 and March 1, 2028.
Kempa will receive 33,000 time-based restricted share units in early January 2027 in lieu of a prorated 2027 bonus.
On October 23, 2026, Freedom Holding and its subsidiary FRHC-IF.SPC Ltd. agreed to issue up to $1.16 billion of five-year U.S. dollar bonds to Kokzhiyek Fund LP, paying 7.8% annual interest. The proceeds can be used only for seven specified projects and are released in stages, and the bonds are guaranteed by the company, a subsidiary and CEO Timur Turlov, so the deal adds a large, secured debt obligation for shareholders to weigh. The filing also says that if a coupon goes unpaid for 90 days, the fund may require the company to issue common stock.
Up to $1,160,000,000 in five-year U.S. dollar bonds at 7.8% per annum, payable semi-annually, to be listed on the Astana International Exchange
Proceeds are released project by project through an escrow account, with the availability period ending December 30, 2028
Bonds are guaranteed by Freedom Holding, Freedom Kazakhstan Ltd. and Mr. Timur Turlov, and secured by pledges including 100% of the equity of each Project Company
If a coupon is unpaid for 90 days, the fund may require share issuance priced at 85% of the 180-day volume-weighted average price; financial covenants begin with the fiscal year ending March 31, 2027
Forestar Group's Executive Chairman, Donald J. Tomnitz, will retire effective October 31, 2026, and CEO Anthony W. Oxley will also serve as Executive Chairman from November 1, 2026. Tomnitz will provide advisory services through September 30, 2028 under a monthly fee of $41,667, and the filing also adds director Stacey H. Dwyer and notes that Samuel R. Fuller will not stand for re-election in 2027.
Donald J. Tomnitz retires as Executive Chairman effective October 31, 2026; he had served in the role since October 2017
Anthony W. Oxley, President and CEO, becomes Executive Chairman effective November 1, 2026, a role designated by D.R. Horton, Inc.
Tomnitz's advisory agreement runs through September 30, 2028 at $41,667 per month, with his RSUs and PSUs continuing to vest
Stacey H. Dwyer joins the Board effective November 1, 2026, and Samuel R. Fuller will not be nominated for re-election at the 2027 Annual Meeting
Markel's insurance subsidiaries entered an Adverse Development Cover Agreement with Cavello Bay Reinsurance, a wholly owned subsidiary of Enstar Group Limited, covering $4.8 billion of net reserves on a run-off global reinsurance portfolio and certain exited lines. Markel will pay a $2.4 billion reinsurance premium, settled through a transfer of assets at closing, and the deal is expected to close by the end of the fourth quarter of 2026 subject to regulatory approval. Markel's press release says the net impact on fourth quarter underwriting results is expected to be immaterial.
Subject reserves of $4.8 billion; Markel retains the first $2.6 billion of covered losses, and the reinsurer covers the next $2.3 billion.
Adverse development coverage of $1.2 billion above the $4.8 billion of reserves.
Reinsurance premium of $2.4 billion, with $500 million of transferred assets sent to the reinsurer outright and the balance placed in a trust account.
Closing expected by the end of the fourth quarter of 2026, subject to regulatory approval; the agreement covers losses paid on or after April 1, 2026.
BRC Group Holdings said its Merger Sub, an indirect wholly owned subsidiary, merged into B. Riley Securities Holdings, Inc. (BRSH) on October 22, 2026, under a short-form merger after owning more than 90% of BRSH's common stock. Shares not held by Merger Sub were converted into the right to receive $8.88 in cash, and BRSH restricted stock awards were replaced with BRC restricted stock awards at twice the share count. The filing also states that Andy Moore's BRSH award was replaced with a substitute award covering 374,720 BRC shares.
Short-form merger effective October 22, 2026, with BRSH surviving as the entity
Shares of BRSH common stock not held by Merger Sub converted into $8.88 cash per share, without interest
Each BRSH restricted stock award replaced by a BRC award covering two times the BRSH share count, rounded down
Andy Moore, CEO of B. Riley Securities and a BRSH director, received a substitute award for 374,720 BRC shares
The 40-day go-shop period for Mistras Group's proposed all-cash sale to H.I.G. Capital affiliates expired at 11:59 p.m. ET on October 27, 2026, with no alternative acquisition proposals received. Shareholders will vote at a special meeting on November 24, 2026, and the deal is expected to close in late 2026 or early 2027, subject to stockholder approval and regulatory approvals.
Go-shop expired 11:59 p.m. ET on October 27, 2026; no alternative proposals were received before expiration
Financial advisor Robert W. Baird contacted or was contacted by 122 third parties, and 40 signed confidentiality agreements
All-cash price of $20.35 per share, an enterprise value of about $866 million including debt, a premium of about 8% and 13% to 30- and 90-day VWAP
Special meeting of stockholders to be held virtually on November 24, 2026; closing expected late 2026 or early 2027
TransCode Therapeutics said its board has started a formal strategic process to evaluate options to maximize the value of the company and its oncology portfolio, including lead candidate TTX-MC138, and has retained Tungsten Advisors as exclusive strategic financial advisor. The filing states there is no assurance the process will produce any transaction, and the company does not plan updates unless the board approves a specific transaction or disclosure is otherwise required.
Board initiated the formal strategic process; announced October 28, 2026
Options listed include licensing or sale of individual assets, partnerships, portfolio transactions and business combinations
Tungsten Advisors engaged as exclusive strategic financial advisor
No updates planned unless a specific transaction is approved or disclosure is required
Zillow Group entered a settlement agreement on October 27, 2026, to resolve the consolidated securities class action Jaeger v. Zillow Group, Inc. The company will pay $212.5 million in cash into an escrow fund within 20 business days after preliminary court approval, with about $48 million expected to come from insurance proceeds. The settlement is subject to court approval and does not affect the related shareholder derivative actions, which remain pending.
Settlement payment totals $212.5 million, with about $48 million expected from insurance proceeds
Payment due within 20 business days after the court preliminarily approves the settlement
Class covers stock purchases from August 5, 2021, to November 2, 2021; agreement includes no admission of liability
Related shareholder derivative actions remain pending and are not resolved by this settlement
Azora Therapeutics, formerly Adial Pharmaceuticals, appointed Matthew Davidson, Ph.D. as President and Chief Executive Officer effective October 28, 2026, succeeding Cary J. Claiborne, whose employment was terminated. The board also appointed Celia Economides as Chief Financial Officer, succeeding Vinay Shah, and Julie Saiki, Ph.D. as Chief Strategy Officer. Stockholders approved increasing authorized common stock from 100,000,000 to 500,000,000 shares and the name change, with the new ticker AZR expected to begin trading October 29, 2026.
Matthew Davidson, Ph.D. appointed President and CEO effective October 28, 2026; Cary J. Claiborne's employment terminated, subject to a release for severance.
Celia Economides appointed CFO, succeeding Vinay Shah, whose employment was terminated effective October 28, 2026.
Authorized common stock increases from 100,000,000 to 500,000,000 shares; the amendment takes effect 12:01 AM Eastern on October 29, 2026.
Stockholders approved issuance of up to 23,561,896 shares on exercise of milestone pre-funded and incentive warrants, among other proposals.
On October 28, 2026, the European Commission closed its preliminary review of AES's pending merger with Horizon Parent, L.P. under the EU Foreign Subsidies Regulation. The clearance is one condition to closing, which still requires certain additional regulatory approvals and customary closing conditions.
European Commission closed its preliminary review on October 28, 2026 under Article 10(4) of Regulation (EU) 2022/2560
The EU Foreign Subsidies Regulation approval is a condition to closing, but the merger remains subject to other regulatory approvals
After closing, AES would be jointly owned by investment vehicles affiliated with Global Infrastructure Management, LLC and the EQT Infrastructure VI fund, among other investors
Effective October 29, 2026, Q2 Holdings named CFO Jonathan Price co-CEO alongside Matthew Flake, who remains president and chairman, and appointed Price to a board expanded from seven to eight members. Price will also keep the CFO role during the company's search for a new CFO, and his pay and severance terms were revised as part of the change.
Effective October 29, 2026, Price becomes co-CEO alongside Flake; the board increases from seven to eight members.
Price's annual base salary rises to $520,000, and he receives an RSU grant valued at $3 million vesting over four years.
Price remains chief financial officer during the search for a new CFO, with no date for that search given in the filing.
Severance is set at 200% of base salary plus a pro-rata bonus, or 250% as a lump sum if terminated within 60 days before to 24 months after a change in control.
FedEx Corporation changed its fiscal year end to December 31 and completed the spin-off of FedEx Freight into a publicly traded company on June 1, 2026. The company also realigned its internal reporting into Express U.S. Domestic and Express International segments and sold its FedEx Supply Chain business for $1.4 billion on October 1, 2026. Supplemental historical financial information has been provided to reflect these structural changes.
Changed fiscal year end from May 31 to December 31, effective June 1, 2026.
Completed spin-off of FedEx Freight on June 1, 2026, presenting it as discontinued operations.
Completed the sale of FedEx Supply Chain to CMA CGM Group for $1.4 billion on October 1, 2026.
Realigned reportable segments into Express U.S. Domestic and Express International.
Align Technology said Jennifer L. Davis, former CEO of Procter & Gamble's Global Healthcare business, will become President and CEO on December 31, 2026, replacing Joseph M. Hogan, who has led the company since 2015 and will retire from the role and become a strategic advisor. Davis joins the Board as a director on November 2, 2026, and the filing sets out her pay package, including a $1,300,000 base salary and a $2,000,000 signing bonus. The change marks a planned leadership transition at the company, and the filing discloses no changes to financial results or guidance.
Jennifer L. Davis joins as CEO-elect and director on November 2, 2026, and becomes President and CEO on December 31, 2026
Joseph M. Hogan, CEO since 2015, retires as CEO on December 31, 2026 and will serve as a strategic advisor under a one-year consulting agreement with a $150,000 annual fee
Davis's pay includes a $1,300,000 base salary, a 150% target bonus, equity awards of $9,900,000 and $6,600,000, and a $2,000,000 signing bonus
Board size increases from ten to eleven directors effective November 2, 2026
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.